Cargando…

Abnormal Dendritic Cell-poiesis in Patients With Lower-risk Myelodysplastic Syndromes

Detalles Bibliográficos
Autores principales:	Sánchez, Ángela, Anguita, Eduardo, Chaparro, Alberto, Roldán-Etcheverry, Juan José, López-García, Alberto, Ramos-Acosta, Carlos, Oancea, Raluca, Rodriguez-Muñoz, Diego, Alemany, Susana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2020
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7000478/ https://www.ncbi.nlm.nih.gov/pubmed/32072149 http://dx.doi.org/10.1097/HS9.0000000000000335

Ejemplares similares

Embryonic ILC-poiesis across tissues
por: Hernández-Torres, Daniela Carolina, et al.
Publicado: (2022)

Transcription Factor GFI1B in Health and Disease
por: Anguita, Eduardo, et al.
Publicado: (2017)

‘ILC-poiesis’: generating tissue ILCs from naïve precursors
por: Di Santo, James P., et al.
Publicado: (2017)

El concepto poíesis en la filosofía griega : Heráclito-Sofistas-Platón /
por: Lledó Íñigo, Emilio
Publicado: (2015)

Reflecting biomedical, technological and environmental issues of our modern society. The recent “Forum” section in Poiesis & Praxis
por: Lingner, Stephan
Publicado: (2011)

Variant Philadelphia t(X;9;22)(q22?;q34;q11.2) can be successfully treated with second generation tyrosine kinase inhibitors: A case report and literature review
por: Iglesias, Ana, et al.
Publicado: (2021)

Abnormal Ferroptosis in Myelodysplastic Syndrome
por: Lv, Qi, et al.
Publicado: (2020)

Rare Cytogenetic Abnormalities in Myelodysplastic Syndromes
por: Bacher, Ulrike, et al.
Publicado: (2015)

Cytogenetic Abnormalities in Myelodysplastic Syndromes: An Overview
por: Zahid, Mohammad Faizan, et al.
Publicado: (2017)

Abnormal Macrophage Polarization in Patients with Myelodysplastic Syndrome
por: Zhang, Gaochao, et al.
Publicado: (2021)

Trisomy 8, a Cytogenetic Abnormality in Myelodysplastic Syndromes, Is Constitutional or Not?
por: Saumell, Sílvia, et al.
Publicado: (2015)

Chromothripsis Is a Recurrent Genomic Abnormality in High-Risk Myelodysplastic Syndromes
por: Abáigar, María, et al.
Publicado: (2016)

Management of patients with lower-risk myelodysplastic syndromes
por: Brunner, Andrew M., et al.
Publicado: (2022)

Chromosomal Abnormalities in Myelodysplastic Syndrome Patients in Upper Northern Thailand
por: Phrommin, Suphitcha, et al.
Publicado: (2020)

EASIX for prediction of survival in lower-risk myelodysplastic syndromes
por: Merz, Almuth, et al.
Publicado: (2019)

Role of Luspatercept in the Management of Lower-Risk Myelodysplastic Syndromes
por: Tinsley-Vance, Sara M., et al.
Publicado: (2023)

Management of Patients with Lower-Risk Myelodysplastic Neoplasms (MDS)
por: Lucero, Josephine, et al.
Publicado: (2023)

FOXP1 and TP63 involvement in the progression of myelodysplastic syndrome with 5q- and additional cytogenetic abnormalities
por: L’Abbate, Alberto, et al.
Publicado: (2014)

Abnormal populations and functions of natural killer cells in patients with myelodysplastic syndromes
por: Zhang, Wei, et al.
Publicado: (2018)

Severe Eosinophilia in Myelodysplastic Syndrome With a Defined and Rare Cytogenetic Abnormality
por: Rai, Shinya, et al.
Publicado: (2019)

Myelodysplastic Syndromes and Iron Chelation Therapy
por: Angelucci, Emanuele, et al.
Publicado: (2017)

Prediction of response to therapy with ezatiostat in lower risk myelodysplastic syndrome
por: Galili, Naomi, et al.
Publicado: (2012)

Lower‐risk myelodysplastic syndromes: Current treatment options for anemia
por: Meunier, Mathieu, et al.
Publicado: (2022)

Salud mental, logoterapia y liberación : alternativas a la globalización neoliberal
por: Etcheverry, Juan Alberto
Publicado: (1999)

Abnormal changes in the quantity and function of osteoblasts cultured in vitro in patients with myelodysplastic syndrome
por: Gao, Shan, et al.
Publicado: (2018)

Treatment options for lower-risk myelodysplastic syndromes. Where are we now?
por: Volpe, Virginia O., et al.
Publicado: (2021)

Prognostic impact of immunophenotypic aberrancies of blasts in lower risk myelodysplastic syndrome
por: Corrao, Kristen, et al.
Publicado: (2022)

Myelodysplastic Syndrome: Riding the Crest of the Wave
por: Ramos, Fernando
Publicado: (2022)

Pyoderma gangrenosum and erythema elevatum diutinum associated with a high-risk myelodysplastic syndrome: case report
por: Vide, Júlia, et al.
Publicado: (2018)

Clinical significance of cytogenetic and molecular genetic abnormalities in 634 Chinese patients with myelodysplastic syndromes
por: Yan, Xuefen, et al.
Publicado: (2021)

Association between abnormal lipid profile and inflammation and progression of myelodysplastic syndrome to acute leukemia
por: Qiao, Wei, et al.
Publicado: (2022)

Profiling myelodysplastic syndromes by mass cytometry demonstrates abnormal progenitor cell phenotype and differentiation
por: Behbehani, Gregory K., et al.
Publicado: (2020)

Abnormal platelet immunophenotypes and percentage of giant platelets in myelodysplastic syndrome: A pilot study
por: Wu, Yi-Feng, et al.
Publicado: (2022)

Reduced Plasmacytoid Dendritic Cell Output Is Associated With High Risk in Low-grade Myelodysplastic Syndrome
por: Chan, Alexander, et al.
Publicado: (2022)

Reduced frequencies and functional impairment of dendritic cell subsets and non-classical monocytes in myelodysplastic syndromes
por: van Leeuwen-Kerkhoff, Nathalie, et al.
Publicado: (2021)

Content validity of patient-reported outcomes for use in lower-risk myelodysplastic syndromes
por: Trudeau, Jeremiah J., et al.
Publicado: (2020)

Activity of luspatercept and ESAs combination for treatment of anemia in lower-risk myelodysplastic syndromes
por: Komrokji, Rami S., et al.
Publicado: (2023)

An abnormal secretion of soluble mediators contributes to the hematopoietic-niche dysfunction in low-risk myelodysplastic syndrome
por: Martini, M, et al.
Publicado: (2015)

Coincidence of cutaneous blastic plasmacytoid dendritic cell neoplasm and myelodysplastic syndrome derived from clonal hematopoiesis
por: Yamada, Tomohiko, et al.
Publicado: (2023)

Evolution of Echocardiographic Abnormalities Identified in Previously Healthy Individuals Recovering from COVID-19
por: Tudoran, Cristina, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_b0o6p4fgcctbhasctvcl4mreoq